Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,650.00
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 83.00 (5.03%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Markets up on positive company news

Wed, 22nd Oct 2014 17:04

The London market closed in positive territory for the second time this week as traders weary of negative economic news took heart from upbeat corporate results.The FTSE 100 Index ended the session 27.4 points ahead at 6399.73 as drug group GlaxoSmithKline pleased investors with news of higher earnings per share despite US and European weakness. It also said it was launching a restructuring drive to cut costs and streamline its business. Glaxo's shares bounced 35p to 1,377p.On the economic front, minutes from the Bank of England's most recent meeting showed no further urge by members to start thinking about raising interest rates, with the split between 'doves' and 'hawks' remaining unchanged from the last meeting at 7-2.Capital Spreads dealer William Nicholls said: "Given the volatility in financial markets of late, there is unlikely to be any move on this sentiment since the meeting, if anything they are likely to become more accommodative."Investors took cover in car insurers after the Automobile Association (AA) said price declines in the industry were over.Admiral Group ticked up 42p to 1285p and Direct Line advanced 8.5p to 279.6p. But the AA itself reversed 2.25p or 0.72% to 310.25p.Supermarkets were on the slide after Waitrose said the business model of the Big Four retailers was outdated and insolvency group Begbies Traynor forecast a bad Christmas unless they make changes.Sainsbury was 8.4p off at 241.6p, Morrisons backtracked 4.2p to 157.9p and Tesco, which releases first-half results tomorrow, fell 2.9p to 183p.British American Tobacco wafted 91.5p lower to 3375p after warning of a foreign exchange hit and weak European markets.Fashion house Supergroup faded 54p to 975p as worries about the impact on sales of warm autumn weather eclipsed news that former Co-op boss Euan Sutherland was to become its new chief executive.Market MoverstechMARK 2,674.09 +1.20%FTSE 100 6,399.73 +0.43%FTSE 250 15,170.06 +0.97%FTSE 100 - RisersAdmiral Group (ADM) 1,285.00p +3.38%Direct Line Insurance Group (DLG) 279.60p +3.14%GlaxoSmithKline (GSK) 1,377.00p +2.61%ARM Holdings (ARM) 827.00p +2.61%Whitbread (WTB) 4,298.00p +2.33%Old Mutual (OML) 181.90p +2.19%Babcock International Group (BAB) 1,079.00p +2.18%Smith & Nephew (SN.) 982.50p +2.13%Dixons Carphone (DC.) 374.30p +2.10%Royal Mail (RMG) 448.70p +1.98%FTSE 100 - FallersSainsbury (J) (SBRY) 241.60p -3.36%Fresnillo (FRES) 784.00p -3.03%British American Tobacco (BATS) 3,375.00p -2.64%Morrison (Wm) Supermarkets (MRW) 157.90p -2.59%Randgold Resources Ltd. (RRS) 4,170.00p -2.55%Rio Tinto (RIO) 3,089.50p -1.61%Tesco (TSCO) 183.00p -1.56%BHP Billiton (BLT) 1,664.50p -1.48%Weir Group (WEIR) 2,258.00p -1.44%Anglo American (AAL) 1,356.50p -1.31%FTSE 250 - RisersPace (PIC) 335.90p +9.20%Zoopla Property Group (WI) (ZPLA) 214.00p +6.47%esure Group (ESUR) 235.00p +5.90%Croda International (CRDA) 2,215.00p +5.83%Laird (LRD) 310.00p +5.19%Playtech (PTEC) 737.50p +5.06%International Personal Finance (IPF) 480.00p +5.03%Keller Group (KLR) 797.50p +4.93%Ophir Energy (OPHR) 209.50p +4.23%Foxtons Group (FOXT) 205.30p +4.21%FTSE 250 - FallersSupergroup (SGP) 975.00p -5.25%Lonmin (LMI) 181.90p -2.83%AO World (AO.) 173.00p -2.54%Cairn Energy (CNE) 157.40p -2.36%Senior (SNR) 268.90p -2.36%Balfour Beatty (BBY) 161.80p -2.35%EnQuest (ENQ) 74.85p -1.84%Entertainment One Limited (ETO) 303.50p -1.78%African Barrick Gold (ABG) 195.00p -1.71%Poundland Group (PLND) 316.50p -1.71%
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.